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INTRODUCTION
Neuroendocrine neoplasm can occur in any organ of the body,
yet it is generally localized in the gastrointestinal system or the
bronchial system. Goldman et al. (1) in 1969 first described laryn-
geal neuroendocrine neoplasm as a distinct clinical and patholog-
ic entity, and over 500 cases of this neoplasm have been report-
ed in the English literature since then. The clinical behavior and
overall prognosis show wide variations between the different tumor
types. In this article, we describe a rare case of a moderately differ-
entiated neuroendocrine carcinoma of the larynx and we summa-
rize the current literature regarding this unusual tumor (2-4).
CASE REPORT
A 59-yr-old man with a history of heavy smoking presented
with a change of voice that he’d experienced for one month. The
patient had no other symptoms. On laryngoscopic examination,
a submucosal mass was seen on the laryngeal surface of the
epiglottis. Both the true vocal cords were mobile (Fig. 1). Two
enlarged lymph nodes were palpable on the neck examination at
the left level II and III areas.
We performed biopsy and mapped the tumor with using a sus-
pension laryngoscope. The tumor had no glottic extension and
the anterior commissure was free of tumor. Histopathologic analy-
sis showed moderately differentiated neuroendocrine carcinoma
(Fig. 2). The CT scan demonstrated a supraglottic mass invading
the pre-epiglottic space, and there were multiple metastatic neck
nodes at the left level II and III areas (Fig. 3). No distant metasta-
tic lesion was noted on the chest X-ray, abdominal sonogram, G-
fiber exam and bone scan.
The patient subsequently underwent supraglottic partial laryn-
gectomy with left radical neck dissection. The histopathology of
the surgical specimens revealed moderately differentiated neu-
roendocrine carcinoma with a tumor-free resection margin. Four
metastatic lymph nodes were identified in the neck dissection speci-
men. The patient’s postoperative course was not complicated except
for a chyle fistula that was resolved with conservative manage-
ment. Postoperative radiation treatment was done on the location
of the primary tumor and both neck areas.
At the 6 months postoperative follow-up exam, the patient
complained of back pain with a tingling sense in the lower leg.
A bone scan showed multiple bone metastases. Multiple metasta-
tic lesions at the T7 and T11 levels with a compression fracture
at the L2 level were identified on the spine MRI scan (Fig. 4).
Radiation therapy was administered on the lumbar spine for the
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pathologic fracture and palliative chemotherapy was also per-
formed, but the patient died from his cancer 3 weeks later.
DISCUSSION
Although neuroendocrine neoplasm of the larynx is uncommon,
it is the most common non-epidermoid neoplasm of this organ.
This tumor can be divided into the epithelial and neural origin
groups. The best-known neural origin tumor is paraganglioma.
The epithelial origin tumors are further subclassified based on the
degree of differentiation (well, moderately, and poorly differen-
tiated carcinoma). Well differentiated neuroendocrine carcinoma
(typical carcinoid) is an extremely rare subtype and it carries the
best prognosis. This tumor is preferably treated by conservative
surgery unless this is expensive, and elective neck dissection is
not indicated. Poorly differentiated or small cell neuroendocrine
carcinoma is similar in appearance and behavior to small cell lung
carcinoma. It is the most highly malignant neoplasm with frequent
metastases and a poor survival rate. The same as for small cell
lung carcinoma, chemotherapy, and radiation therapy are the
preferred treatment modalities (2, 5, 6).
Fig. 1. Laryngoscopic image showing a submucosal mass involving
laryngeal surface of the epiglottis. Both true vocal cords are mobile and
the tumor has no glottic extension. Anterior commisure is free of tumor.
Fig. 2. Pathologic pictures. (A) Low power view with overlying intact mucosa (hematoxylin-eosin [H&E], magnification ×20). (B) High-power view
showing pseudogland and rodget arrangement as a neuroendocrine differentiation (H&E, magnification ×200). (C) Cord and trabecular arrange-
ment with nuclear and cellular pleomorphism (H&E, magnification ×200). (D) Tumor necrosis area (arrow) (H&E, magnification ×200). (E) Positive
immunoreaction to chromogranin (magnification ×200). (F) Positive immunoreaction to synaptophysin (magnification ×200).
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Fig. 3. The contrast-enhanced CT scans. (A) Supraglottic tumor invades the pre-epiglottic space. (B) Multiple neck metastases are seen at the
left level II, III areas.
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Fig. 4. At the follow-up of 6 months after operation. (A) Laryngoscopic image shows postradiation edema around previous operative area. But there
is no evidence of local recurrence. (B) Bone scan image demonstrates multiple bone metastases (rib, spine, shoulder, skull base). (C) T1-weight-
ed sagittal MRI scan shows metastatic lesions at T7, T11 level with compression fracture at L2 level (arrows). (D) Expansile metastatic lesion is
noted at the right 7th rib (T1-weighted axial MRI scan, arrow).220 Clinical and Experimental Otorhinolaryngology  Vol. 1, No. 4: 217-220, December 2008
The neuroendocrine neoplasm that’s caused the greatest diag-
nostic confusion for moderately differentiated neuroendocrine
carcinoma is laryngeal paraganglioma. However, its biological
behavior is typically benign (2, 3, 7). Complete surgical resection
is the treatment of choice; elective neck dissection is not neces-
sary and metastasis is very rare. Overall, the prognosis for patients
with this tumor is excellent (2, 8).
Moderately differentiated neuroendocrine carcinoma (atypi-
cal carcinoid) is the most common neuroendocrine tumor of the
larynx. It is more common in the older age men (6th decade) who
have a history of cigarette smoking. The vast majority of this tumor
shows a supraglottic origin (5). The diagnosis may be difficult,
especially on the initial biopsy evaluation, but making a precise
diagnosis is crucial for selecting the proper therapy and achiev-
ing a good patient outcome. In contrast with well differentiated
laryngeal tumor, mitosis, cellular pleomorphism, and necrosis are
the critical features for the diagnosis. Immunohistochemical stain-
ing is important for making the correct diagnosis of atypical car-
cinoid. Carcinoma cells are usually positive for markers such as
chromogranin, synaptophysin, keratin, calcitonin and carcinoem-
bryonic antigen. The final diagnosis should not be based solely
on the presence or absence of a single immunohistochemical stain
marker, and a panel of immunohistochemical antibodies should
be utilized (3, 5, 8). Unlike well differentiated laryngeal tumor,
moderately differentiated neuroendocrine carcinoma of the lar-
ynx is an aggressive and potentially widely metastasizing malig-
nancy. Nodal metastases are frequent and distant metastases are
not uncommon (2). The ideal therapy remains a subject of debate.
Complete surgical removal is recommended and supraglottic laryn-
gectomy is often indicated when considering the primary site of
the lesion. Bilateral elective neck treatment should be performed
for the N0 cases because of the high risk of cervical lymph node
metastases. This tumor is reported to be radiotherapy and chemo
therapy resistant. However, the addition of radiation therapy
appears warranted for cases of local extension, multiple nodal
metastases or extracapsular disease (5, 8, 9). Batsakis et al. (10)
reported that elevated calcitonin levels could be regarded as a
specific marker for laryngeal atypical carcinoid. However, Mcbride
et al. (2) revealed that an elevated serum calcitonin level was
almost always present in patients with medullary thyroid carci-
noma, but an elevated serum calcitonin level has been only occa-
sionally reported in patients with atypical laryngeal carcinoid. Fu-
ture studies will be required to investigate the role of calcitonin
as a postoperative follow-up tool. In a minority of cases, parane-
oplastic syndrome may precede the clinical manifestation of per-
sistent or recurrent tumor, or asymptomatic metastases (7). The
5-yr survival rate is approximately 50%, and the 10-yr survival
rate is only 30% (2, 8).
In conclusion, this heterogeneous group of disorders has dif-
ferent prognoses and rational for their management. Therefore,
a precise histological diagnosis is crucial for administering the
appropriate therapy.
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